Silicone dressings reduce painful skin reactions following radiation for breast cancer, study finds

November 1, 2012
The dressing has been applied to one side (M). The difference in skin reaction is apparent.

(Medical Xpress)—Skin reactions following radiation therapy for breast cancer have been the focus of a recent clinical trial conducted by Dr Patries Herst from the Department of Radiation Therapy, University of Otago, Wellington and a team of radiation therapists in public hospitals in Dunedin, Wellington and Palmerston North and Auckland Radiation Oncology.

The findings of the study, recently published in the international journal Cancer Science and Therapy, show that silicone based dressings decrease painful caused by better than conventional aqueous cream.

The investigated the effect of silicone based Mepilex Lite dressings on the severity of painful skin reactions experienced by 80 women treated with radiation therapy for . The affected skin was divided into two equal halves; one half was randomized to be treated with dressings and the other with aqueous control cream.

The dressings decreased both the visible signs of the skin reactions as well as the severity of the symptoms. Most patients preferred the dressings over the cream and found them easy to use and comfortable to wear.

"These results will be of great benefit to people undergoing radiation therapy for breast and head and neck cancers as radiation can cause severe skin reactions by damaging the cells responsible for skin renewal and this really impacts on their quality of life," says lead researcher Dr Patries Herst.

The severity of the reactions varies from redness to flaking to weeping and ulceration. Severe skin reactions are extremely painful particularly in places where clothing rubs and presses on the damaged skin. There is currently no standard treatment for these skin reactions.

The dressings do not contain any chemicals but stop friction between the fragile skin and clothing, giving the radiation damaged skin time to heal. A very thin layer of silicon allows the dressings to stick closely to healthy skin but not to weeping skin, making them easy and painless to remove.

Dr Herst is continuing her investigations into the use of these dressings and hopes that they will become part of standard care in radiation therapy departments in New Zealand in the near future.

Breast cancer is the most common malignancy in New Zealand women; around 2800 women are diagnosed every year, with a significant number receiving radiation therapy as part of their treatment.

Explore further: Vitamin C may enhance radiation therapy for aggressive brain tumors

Related Stories

Vitamin C may enhance radiation therapy for aggressive brain tumors

February 17, 2012
Recent research by the University of Otago, Wellington has shown that giving brain cancer cells high dose vitamin C makes them much more susceptible to radiation therapy.

IMRT reduces risk of side effects in breast cancer patients

March 28, 2012
Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical ...

Radiation at time of lumpectomy may offer faster, more precise treatment for breast cancer patients

April 12, 2011
Northwestern Medicine physicians are currently utilizing a new treatment option for breast cancer that allows women to receive a full dose of radiation therapy during breast conserving surgery. Traditionally, women who opt ...

New skin patch treatment kills most common form of skin cancer

June 11, 2012
A customized patch treatment for basal cell carcinoma completely destroys facial tumors without surgery or major radiation therapy in 80 percent of patients studied, say researchers at the Society of Nuclear Medicine's 2012 ...

Recommended for you

Study prompts new ideas on cancers' origins

December 16, 2017
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the ...

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.